Publications by authors named "E Dauden"

Claim this Profile
S
Survival of Interleukin-17 and Interleukin-23 Inhibitors in Patients Previously Treated with a Tumor Necrosis Factor Inhibitor: Analysis of the Spanish Biobadaderm Registry.
Raquel Rivera-Díaz, Alicia Quesada, Antonio Sahuquillo-Torralba, Esteban Daudén, José Manuel Carrascosa

Actas Dermosifiliogr· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world drug survival of tildrakizumab for plaque psoriasis: a 3-year international multicentre retrospective study.
Tiago Torres, Siddhartha Sood, Orhan Yilmaz, Ronald B Vender, Vimal H Prajapati, Esteban Dauden

Clin Exp Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Well-Being in Psoriasis: Weighting its Components Using Best-worst Scaling Methodology.
Esteban Daudén, Isabel Belinchón, Elena Colominas-González, Pablo Coto, Pablo de la Cueva

Dermatol Ther (Heidelb)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Expression of Galectin-1 and Galectin-9 in Immune-Mediated Inflammatory Diseases.
Cristina Valero-Martínez, Marisa Pardines-Ortiz, Nuria Montes, Esteban Dauden, Benjamín Fernández-Gutierrez

Int J Mol Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Well-Being in Value-Based Routine Care Using Tildrakizumab: 52-week Interim Data of the Phase IV Positive Study.
Ulrich Mrowietz, Rachel Sommer, Sascha Gerdes, Ziad Reguiai, Wolfgang Weger

Psoriasis (Auckl)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis